Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mirati Therapeutics Inc (NASDAQ:MRTX)

6.61
Delayed Data
As of Sep 30
 +0.09 / +1.38%
Today’s Change
4.40
Today|||52-Week Range
43.20
-79.08%
Year-to-Date
No recent news for Mirati Therapeutics Inc.

Today’s Trading

Previous close6.52
Today’s open6.55
Day’s range6.43 - 6.75
Volume210,359
Average volume (3 months)404,084
Market cap$131.7M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-17.90%
Earnings growth (this year)-16.61%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.05+1.61%
ECYTEndocyte Inc-0.03-0.96%
KURAKura Oncology Inc+0.09+1.46%
OCXOncoCyte Corp-0.19-3.63%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$1.16
Annual revenue (last year)$0.00
Annual profit (last year)-$64.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
Chief Financial Officer &
Senior Vice President
Jamie A. Donadio
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs